Effect of bile acid composition and manipulation of enterohepatic circulation on leptin gene regulation.
In the rat, the ob gene product, leptin, putatively regulates energy balance via appetite control and energy expenditure. Bile acids in the intestinal lumen are necessary for efficient absorption of dietary lipids and may trigger the release of regulatory peptides. To investigate whether bile acids play a role in leptin gene expression, we altered the bile acid pool and then measured leptin mRNA levels in adipose tissue. Rats fed cholic acid (1% of chow wt/wt) for 2 weeks did not gain weight as rapidly as pair-fed control animals. Despite the lower weight, normalized leptin mRNA levels were 24% greater in cholic acid-fed rats compared with controls. Conversely, cholestyramine, a bile acid sequestrant, in chow (5% wt/wt) resulted in a 26% decline in leptin mRNA. Ligation of the common bile duct or chronic biliary diversion, experimental manipulations that decreased the intestinal concentration of bile salts, decreased leptin gene expression by 30% and 50%, respectively. A fluid and electrolyte (F/E) solution with and without taurocholate (36 micromol/h x 100 g rat[-1]) was then infused for 12 hours into the duodenum in animals with chronic biliary diversion. Taurocholate infusion resulted in a fourfold increase in steady-state adipocyte leptin mRNA levels compared with F/E infusion. Intravenous infusion of taurocholate or incubation of cultured adipocytes with taurocholate had no effect on leptin mRNA levels. We conclude that bile acids upregulate leptin gene expression indirectly, probably via effects on the absorption of dietary lipids or the release of neurohumoral mediators.
Levy
J R
JR
Section of Endocrinology and Gastroenterology, McGuire Veterans Administration Medical Center and Medical College of Virginia, Richmond 23249, USA.
Heuman
D M
DM
Pandak
W M
WM
Stevens
W
W
D017667:Adipocytes / Q000378:metabolism; D000818:Animals; D001647:Bile Acids and Salts / Q000032:analysis / Q000502:physiology*; D002478:Cells, Cultured; D002792:Cholestyramine Resin / Q000008:administration & dosage / Q000494:pharmacology; D019826:Cholic Acid; D002793:Cholic Acids / Q000008:administration & dosage / Q000494:pharmacology; D003135:Common Bile Duct; D003250:Constriction; D004764:Enterohepatic Circulation / Q000502:physiology*; D005786:Gene Expression Regulation / Q000187:drug effects; D020738:Leptin; D008297:Male; D011506:Proteins / Q000235:genetics*; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D013656:Taurocholic Acid / Q000008:administration & dosage / Q000494:pharmacology
D001647:Bile Acids and Salts; D002793:Cholic Acids; D020738:Leptin; D011506:Proteins; D012333:RNA, Messenger; D002792:Cholestyramine Resin; D013656:Taurocholic Acid; D019826:Cholic Acid